Boston Scientific launches $2B accelerated share buyback as part of $5B repurchase plan

Boston Scientific announced a $2 billion accelerated share repurchase (ASR) agreement with JPMorgan Chase, acquiring about 30.4 million shares based on May 15 closing prices. This ASR is part of a larger $5 billion share repurchase authorization, leaving $3 billion available after this transaction. The final number of shares repurchased will depend on the average stock price during the ASR period, with completion expected by June 30, 2026. The buyback is expected to increase adjusted earnings per share by $0.02 in 2026, supporting the company’s earnings guidance.